Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,667,792
+$7,348,177 QoQ
Shares Held
909,814
+58.0% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 257 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Sep 30, 2025CallValue
$453,004
CallShares
207,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. ERAS ranks #59 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,667,792 | 909,814 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,319,615 | 575,996 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,325,177 | 2,237,951 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $453,004 | 207,800 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $6,354,305 | 2,914,819 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $295,529 | 232,700 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $4,823,443 | 3,797,987 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,417,589 | 3,224,518 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,486,529 | 4,177,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,580,801 | 2,410,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,922,864 | 814,773 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,377,507 | 1,154,130 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,162,215 | 1,484,608 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $819,730 | 416,107 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,285,879 | 1,190,536 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,859,681 | 1,614,512 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,409,533 | 327,038 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,811,689 | 360,473 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $436,919 | 20,590 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||